Saphris
Product Images NDC 16590-936

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Saphris (NDC 16590-936). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Saphris 10mg Label 936)

Label for SAPHRIS 10mg sublingual tablets, 60 count, packaged by STAT RX USA LLC in Gainesville, GA. The label notes the active ingredient as asenapine 10mg (as maleate) with mannitol USP, and indicates storage instructions and cautionary statements including 'Rx Only' and 'Keep out of reach of children.'*

FDA Label Image

Chemical Structure (Saphris 01)

Chemical structure diagram showing the molecular formula of the active ingredient in SAPHRIS by STAT RX USA LLC. The structure includes a chlorine-substituted aromatic ring, a fused bicyclic system with nitrogen and oxygen atoms, and an associated molecule with carboxylic acid groups.*

FDA Label Image

Figure 1 (Saphris 02)

Kaplan-Meier estimation chart depicting the percent relapse or impending relapse over time (days) comparing SAPHRIS (as indicated by asenapine) to placebo. The y-axis shows percent relapse, and the x-axis shows time in days up to 225. The graph shows a lower relapse rate with asenapine versus placebo throughout the observed period.*

FDA Label Image

Figure (Saphris 03)

Instructional diagram showing how to remove and administer a SAPHRIS tablet. Steps include pressing and pulling the tablet pack thumb button, peeling back a colored tab, gently removing the tablet without crushing, placing the tablet under the tongue to dissolve fully without chewing or swallowing, and sliding the tablet pack back into the case until it clicks. Includes warnings to use dry hands and avoid eating or drinking for 10 minutes after administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.